The largest database of trusted experimental protocols

9 protocols using x tremegene sirna reagent

1

Cell Culture and Transient Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
hTERT-RPE-1 (called RPE throughout) and MDA-MB-231 cells were maintained in DMEM with 10% fetal bovine serum, 1% penicillin/streptomycin, and l-glutamine. SK-N-AS cells were maintained in DMEM/F-12 (Gibco) with 10% fetal bovine serum, 1% penicillin/streptomycin, and l-glutamine. H2591 cells were maintained in RPMI 1640 medium (Gibco) with 10% fetal bovine serum, 1% penicillin/streptomycin, and l-glutamine. Transient transfection experiments with miRNA mimics or inhibitors were performed using X-tremeGENE siRNA reagent (Roche Applied Science) in Opti-MEM I media overnight (∼12 h). Media were changed to DMEM or DMEM/F-12 or RPMI 1640 medium as appropriate following the overnight incubation, and cells were collected at 72 h following transfection. Each miRNA experiment represents the average of at least two different transfections for each miRNA mimic or inhibitor. Transient transfection experiments with KDM4A siRNA were co-transfected with the miRNA using X-tremeGENE siRNA reagent (Roche Applied Science) in Opti-MEM I media overnight. Silencer Select siRNA for KDM4A was purchased from Life Technologies, Inc. (s18636).
+ Open protocol
+ Expand
2

EGFP-expressing HeLa Cell Transfection

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa:EGFP64 cells12 (link) were seeded at ~100 000 cells per well into 6-well plates (BD Falcon) and incubated overnight in DMEM growth media supplemented with 10% FBS and 2% penicillin/streptomycin at 37 °C in 5% CO2. Transfections were performed with 50200 nM of each SSO using 5 μL of X-tremeGENE siRNA reagent (Roche) in 1 mL of Opti-Mem (Invitrogen) at 37 °C for 4 h, at which point the transfection mixtures were removed from the cells and replaced with DMEM growth media. After trans-fection, UV irradiations were performed as described above followed by 24 h incubation. Cells were then trypsinized with 500 μL of TrypLE (Invitrogen), washed, and resuspended in 300 μL of PBS, pH 7.4, for fluorescent analysis. Flow cytometry was performed on a FACSCalibur (Becton-Dickinson) instrument (488 nm argon laser, 530/50 nm BPF) and analyzed using Cellquest Pro software. Cells were gated for EGFP fluorescence (above 102.5 RFUs) and analyzed until 20 000 cells had been counted for each condition tested. The frequency of EGFP positive cells (gated/total) was normalized to the noncaged control SSO. Error bars represent the standard deviation of experimental triplicates.
+ Open protocol
+ Expand
3

HeLa Cell Transfection with SSOs

Check if the same lab product or an alternative is used in the 5 most similar protocols
HeLa:EGFP654 cells were seeded at ~10 000 cells per well into black clear bottom 96-well plates (BD Falcon) and incubated overnight in DMEM growth media supplemented with 10% FBS and 2% penicillin/streptomycin at 37 °C in 5% CO2. Transfections were performed with 50200 nM of each SSO using 1 μL of X-tremeGENE siRNA reagent (Roche) in 200 μL of Opti-Mem (Invitrogen) at 37 °C for 4 h. After 4 h, the Opti-Mem transfection mixtures were removed from the cells and replaced with DMEM growth media.
+ Open protocol
+ Expand
4

siRNA-Mediated Silencing of EF1A

Check if the same lab product or an alternative is used in the 5 most similar protocols
siRNA against EF1A (GenePharma) was used for transfection. The sequence of the siRNA strands was as follows: 5′-GUGGUAUUACCAUUGACAUTT-3′ (sense) and 5′-AUGUCAAUGGUAAUAACCACTT-3′ (antisense). Transfection with siRNA was performed with X-tremeGENE siRNA reagent (Roche) by following the manufacturer's instructions. ST cells were cultured overnight in six-well tissue culture plates. The siRNA (20 nM) was complexed with X-tremeGENE siRNA reagent by incubating together at room temperature for 30 min. After removing the cell culture supernatant, the complex was added for incubation 36 h.
+ Open protocol
+ Expand
5

siRNA-mediated TERT knockdown in fibroblasts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells (FB-TERT fibroblasts) were plated prior to transfection for a period of 24 h. They were then transfected with hTERT siRNA using X-treme gene siRNA reagent (Roche Diagnostics, Basel, Switzerland). The siRNAs were synthesized by Shanghai GenePharma Co., Ltd. (Zhangjiang Hi-Tech Park, Shanghai). The siRNA sequences were as follows: hTERT siRNA sense, 5′-GGAAGAGUGUCUGGAGCAATT-3′ and antisense, 5′-UUGCUCCAGACACUCUUCCTT-3′. The negative control (scramble) siRNA sequence was as follows: sense, 5′-UUCU CCGAACGUGUCACGUTT-3′ and antisense, 5′-ACGUGACACGUUCGGAGAATT-3′.
+ Open protocol
+ Expand
6

Genetic Manipulation of Cellular Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
RAGE short hairpin RNA (shRNA), ATG5 shRNA, Beclin1 shRNA, p65 shRNA, and control shRNA were obtained from Sigma, whereas pUNO1-RAGE cDNA was obtained from InvivoGene (San Diego, CA, USA). These shRNAs or cDNA were transfected into cells using the Lipofectamine 2000 reagent (Life Technologies, Carlsbad, CA, USA) according to the manufacturer's instructions. To generate stable shRNA-expressing lines, positive cells were selected with 1–2 μg/ml puromycin for two to three weeks. HIF1α- small interfering RNA (siRNA) and control siRNA from Santa Cruz Technology were transfected into cells using X-tremeGENE siRNA reagent (Roche Applied Science, Stockholm, Sweden) according to the manufacturer's instructions.
+ Open protocol
+ Expand
7

Cisplatin Sensitivity Assay in MDA-MB-231 Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
5000 MDA-MB-231 cells were plated overnight in each well of a 96-well plate. Cells were transfected with miRNA inhibitors using X-tremeGENE siRNA reagent (Roche Applied Science) in Opti-MEM I media overnight (∼12 h). Media were changed to DMEM following the overnight incubation, and cells were allowed to recover for 8 h. Cisplatin (Abcam ab141398) was resuspended in 0.9% NaCl right before use. Cisplatin was added following the 8-h recovery to a final concentration of 300 μm. Cells were processed using Cell Proliferation Kit I MTT (Roche Applied Science) 48 h after addition of cisplatin following the manufacturer's instructions. Each experiment consisted of four technical replicate wells that were averaged together and then taken as a ratio to the no-cisplatin sample. The data presented are the average of eight biological replicates.
+ Open protocol
+ Expand
8

MiR-1225-5p Modulation of IRS1

Check if the same lab product or an alternative is used in the 5 most similar protocols
MiR-1225-5p mimic was purchased from Dharmacon (Lafayette, Colorado, USA). SiRNA Duplex Oligonucleotides Mix targeting human IRS1 mRNA was purchased from Santa Cruz (California, USA). Oligonucleotide transfection was performed with X-tremeGENE siRNA reagent (Roche).
+ Open protocol
+ Expand
9

Lentiviral EMP2 Overexpression & Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
Complementary DNA (cDNA) of EMP2 was synthesized by Genewiz (Beijing, China). EMP2 expression was stably overexpressed using a lentiviral vector with elongation factor-1 alpha (EF-1 alpha) promoter and puromycin selectable marker. Three individual EMP2-specific small interfering RNAs (siRNAs) were purchased from Thermo Scientific. Universal scrambled negative control siRNA was purchased from Ruibo (Guangzhou, China). SiRNA transfection was performed by using X-tremeGENE siRNA reagent (Roche) according to manufacturer's instructions.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!